Latest debt-to-equity ratio
Voyager Therapeutics Debt-to-equity ratio
Direct answer
Voyager Therapeutics's debt-to-equity ratio is 21.1%.
The verified market snapshot reports 21.1%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 7, 2026.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 21.1%
Explore related company data
View Voyager Therapeutics's market capitalizationView Voyager Therapeutics's price-to-book ratioView Voyager Therapeutics's return on equityView Voyager Therapeutics's dividend yieldView Voyager Therapeutics's 52-week price rangeView Voyager Therapeutics's revenue growthView Voyager Therapeutics's profit marginView all Voyager Therapeutics key metricsReturn to Voyager Therapeutics profile